ArticlePloS one2025
Hyperglycemia and bladder cancer prognosis in a Finnish population-based cohort.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes might increase risk of bladder cancer (BCa) incidence and bladder cancer specific death.
objectiveTo assess the potential association between diabetes and prognosis of BCa. DESIGN, SETTING AND
participantsRegister-based cohort study included 14,638 participants with BCa diagnosed in Finland during 1995-2012. Three databases were used to obtain information on BCa, diabetes and comorbidities. Hyperglycemia was determined by blood glucose or HbA1c. The role of antidiabetic medication use was also assessed. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Associations between diabetes and BCa-specific and overall mortality were evaluated using multivariable Cox regression models. RESULTS AND LIMITATION: During median follow-up of 4.3 years after BCa diagnosis 3,582 (24.5%) participants died of BCa. Diabetic post-diagnostic blood glucose level was associated with worse BCa-specific HR 1.58 (1.10-2.28) and overall survival HR 1.50 (1.20-1.89). The risk increase was slightly lower among hyperglycemic DM medication users (HR 1.43 (0,68-3.02) than non-users HR 1.80 (1.13-2.85). The main limitation of this study was insufficient information on tobacco smoking.
conclusionsDiabetes and diabetic glycemic status were associated with increased risk of both overall and BCa-specific death. PATIENT SUMMARY: In a Finnish population-based cohort study, diabetic bladder cancer patients had worse prognosis compared to non-diabetics. This was observed in both genders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.